Holen Sie sich die Stockscreener-App
21.65
0.69%
-0.19
Schlusskurs vom Vortag:
$21.84
Offen:
$21.63
24-Stunden-Volumen:
395.30K
Relative Volume:
0.25
Marktkapitalisierung:
$2.45B
Einnahmen:
$6.94M
Nettoeinkommen (Verlust:
$-212.39M
KGV:
-8.9168
EPS:
-2.428
Netto-Cashflow:
$-200.60M
1W Leistung:
+12.38%
1M Leistung:
+3.09%
6M Leistung:
+50.52%
1J Leistung:
+265.77%
1-Tages-Spanne:
$21.62
$22.40
1-Wochen-Bereich:
$20.37
$23.14
52-Wochen-Spanne:
$5.1501
$27.65
Immunome Inc Stock (IMNM) Company Profile
Firmenname
Immunome Inc
Sektor
Branche
Telefon
610-321-3700
Adresse
18702 N. CREEK PARKWAY, BOTHELL
Compare IMNM vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
21.69 | 2.47B | 6.94M | -212.39M | -200.60M | -2.428 |
VRTX
Vertex Pharmaceuticals Inc
|
433.68 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.51 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.60 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
331.03 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.76 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-12-01 | Eingeleitet | Truist | Buy |
| 2025-09-22 | Eingeleitet | Goldman | Buy |
| 2025-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2025-04-02 | Eingeleitet | Lake Street | Buy |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-30 | Eingeleitet | JP Morgan | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-01-29 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-19 | Eingeleitet | Wedbush | Outperform |
| 2021-10-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Immunome Inc Aktie (IMNM) Neueste Nachrichten
Immunome CSO Sells Shares: Transaction Details & Company SnapshotNews and Statistics - IndexBox
Immunome (IMNM) Is Up 11.4% After CEO Share Buy And Positive Phase III DataWhat's Changed - Sahm
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - AOL.com
Insider Sell: What is the long term forecast for Immunome Inc stockDividend Hike & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - The Motley Fool
A Look At Immunome (IMNM) Valuation After Oncology Progress EPS Upgrades And CEO Insider Buying - Sahm
Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance Singapore
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock By Investing.com - Investing.com Canada
Immunome CFO Rosett sells $1.4m in shares By Investing.com - Investing.com Canada
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock - Investing.com
Immunome CFO Rosett sells $1.4m in shares - Investing.com
Insider Selling: Immunome (NASDAQ:IMNM) Insider Sells 9,438 Shares of Stock - MarketBeat
Insider Selling: Immunome (NASDAQ:IMNM) CFO Sells $1,424,800.00 in Stock - MarketBeat
Immunome (IMNM) CSO pre-planned 9,438-share sale under Rule 10b5-1 - Stock Titan
Immunome (IMNM) CFO exercises 71,561 options and sells 65,000 shares - Stock Titan
IMNM (NASDAQ: IMNM) Form 144/A: 65,000 shares proposed sale via Fidelity - Stock Titan
Tema Etfs LLC Has $2.19 Million Position in Immunome, Inc. $IMNM - MarketBeat
SG Americas Securities LLC Raises Stock Position in Immunome, Inc. $IMNM - MarketBeat
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Immunome reports inducement grants under Nasdaq listing rule 5635(c)(4) - marketscreener.com
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Proposed common-share sale reported by IMNM (NASDAQ: IMNM) - Stock Titan
IMNM (NASDAQ: IMNM) files Form 144 for proposed stock sales - Stock Titan
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last? - qz.com
Immunome (NASDAQ: IMNM) CSO gifts 6,291 shares, retains 31,438 - Stock Titan
Immunome (IMNM) Surges by 13.3%: Can This Momentum Continue? - Bitget
Tuesday’s insider activity: CEO doubles down on biotech stock By Investing.com - za.investing.com
Volume Summary: Can Immunome Inc be the next market leader2026 Trade Ideas & Growth Focused Stock Pick Reports - baoquankhu1.vn
Goldman Sachs Initiates Coverage of Immunome (IMNM) with Buy Recommendation - MSN
Immunome (NASDAQ:IMNM) Stock Price Up 9.4%What's Next? - MarketBeat
Insider Buying: Clay Siegall Acquires Shares of Immunome Inc (IM - gurufocus.com
Immunome Insider Bought Shares Worth $500,602, According to a Recent SEC Filing - marketscreener.com
Immunome CEO Clay Siegall buys $500k in shares By Investing.com - Investing.com South Africa
Immunome CEO Clay Siegall buys $500k in shares - investing.com
Immunome (IMNM) CEO adds 25,450 shares in $19.67 stock purchase - Stock Titan
Immunome Inc Stock: Clinical-Stage Biotech Targeting Cancer and Infectious Diseases with Innovative - AD HOC NEWS
Recap Report: What is the long term forecast for Immunome Inc stockWeekly Investment Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
Vanguard disaggregates holdings; IMNM shows 0 shares after realignment (IMNM) - Stock Titan
Don't Ignore The Insider Selling In Immunome - simplywall.st
Immunome Insider Sold Shares Worth $1,335,626, According to a Recent SEC Filing - marketscreener.com
Immunome Inc: director Wagenheim sells $1.3m in shares By Investing.com - Investing.com UK
Director Philip Wagenheim Sells 65,000 Shares of Immunome Inc (I - gurufocus.com
Immunome (NASDAQ:IMNM) Director Philip Wagenheim Sells 28,200 Shares - MarketBeat
Philip Wagenheim Sells 36,800 Shares of Immunome (NASDAQ:IMNM) Stock - marketbeat.com
Immunome Inc: director Wagenheim sells $1.3m in shares - Investing.com
Immunome (IMNM) director sells 65,000 shares in open market - Stock Titan
IMNM PE Ratio & Valuation, Is IMNM Overvalued - intellectia.ai
Immunome Inc stock surges on breakthrough oncology data, drawing DACH biotech investor interest - AD HOC NEWS
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Form 144 Immunome Inc. For: 20 March By Investing.com - Investing.com Australia
Smart Money: Is Immunome Inc forming a breakout patternQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Finanzdaten der Immunome Inc-Aktie (IMNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immunome Inc-Aktie (IMNM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rosett Max | Chief Financial Officer |
Apr 02 '26 |
Option Exercise |
1.22 |
71,561 |
87,053 |
119,037 |
| Rosett Max | Chief Financial Officer |
Apr 02 '26 |
Sale |
21.92 |
65,000 |
1,424,916 |
54,037 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):